Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Glaxosmithkline Asia
Location
T. Score
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

GLAXOSMITHKLINE ASIA PRIVATE LIMITED

www.gsk-india.com

Active

Updated: 21 Oct 2024

Glaxosmithkline Asia Private Limited, is an unlisted private company incorporated on 18 October, 1995. It is classified as a private limited company and is located in Patiala, Punjab. It's authorized share capital is INR 10.00 cr and the total paid-up capital is INR 5.50 cr.

Glaxosmithkline Asia's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 7.51% over the previous year. At the same time, it's book networth has decreased by 16.22%.

Industry

Community, Personal and Social Services

Products

Sumo Cold Medicine, Vitamin Tablet, Paracetamol Tablet, Paracetamol Syrup, Cetirizine Tablet, Combiflam

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales

18.16%

₹ GET PRO

EBITDA

48.96%

₹ GET PRO

Net Profit

48.13%

₹ GET PRO

Networth

-5.13%

₹ GET PRO

Borrowings

₹ GET PRO

Assets

4.37%

₹ GET PRO

Gross Margin

0.4

GET PRO %

Operating Margin

4.75

GET PRO %

Net Profit Margin

3.47

GET PRO %

Return on Equity

9.33

GET PRO %

ROCE

11.35

GET PRO %

Debt to Equity

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (26)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2016	Mar 2017	Mar 2018	Mar 2019
Equity Capital	5.5	5.5	5.5	5.5
Reserves	1,555.9	731.2	686.4	1,005.7
Borrowings +	7.1	11.2	11.3	-
Long term borrowings	-	-	-	-
Short term borrowings	7.1	11.2	11.3	-
Trade payables +	209.8	248.1	331.6	293.7
Days payable	221.0	186.0	334.0	375.0
Other liabilities +	323.7	446.5	516.7	456.6
Other non-current liabilities	56.5	60.0	27.3	18.8
Other current liabilities	57.4	138.5	157.8	144.1
Total liabilities	1,892.2	1,194.5	1,220.0	1,467.8
Fixed Assets +	130.2	113.1	88.9	36.7
Tangible assets	109.0	110.8	88.3	35.8
CWIP	21.2	2.1	0.5	0.9
Intangible assets	-	0.2	0.1	-
LT loans and advances	0.3	0.6	0.6	-
Other non-current assets	122.1	134.2	172.3	202.2
Current assets +	1,639.5	946.6	958.2	1,228.8
Inventories	287.0	416.7	81.9	61.3
Trade receivables	107.4	158.0	108.1	99.0
Cash and cash equivalents	643.5	314.3	371.2	570.0
ST loans and advances	0.3	0.4	0.2	0.5
Other current assets	601.3	57.2	396.8	498.1
Total assets	1,892.2	1,194.5	1,220.0	1,467.8

Percentage of assets	Mar 2016	Mar 2017	Mar 2018	Mar 2019
Equity Capital	0.29	0.46	0.45	0.37
Reserves	82.23	61.22	56.26	68.52
Borrowings +	0.37	0.94	0.93	0.0
Long term borrowings	0.0	0.0	0.0	0.0
Short term borrowings	0.37	0.94	0.93	0.0
Trade payables	11.09	20.77	27.18	20.01
Other liabilities +	17.11	37.38	42.36	31.11
Other non-current liabilities	2.98	5.02	2.24	1.28
Other current liabilities	3.04	11.59	12.93	9.81
Total liabilities
Fixed Assets +	6.88	9.47	7.29	2.5
Tangible assets	5.76	9.27	7.24	2.44
CWIP	1.12	0.18	0.04	0.06
Intangible assets	0.0	0.02	0.01	0.0
LT loans and advances	0.02	0.05	0.05	0.01
Other non-current assets	6.46	11.24	14.12	13.77
Current assets +	86.65	79.25	78.54	83.72
Inventories	15.17	34.89	6.71	4.18
Trade receivables	5.68	13.23	8.86	6.74
Cash and cash equivalents	34.01	26.31	30.43	38.83
ST loans and advances	0.02	0.04	0.02	0.03
Other current assets	31.78	4.78	32.52	33.93
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2016	Mar 2017	Mar 2018	Mar 2019
Sales +	1,212.5	1,492.7	1,230.3	1,527.5
Sales growth %	None	23.1	-17.58	24.15
Expenses +	905.8	1,386.3	1,224.5	1,169.6
Cost of goods	345.9	487.8	362.0	285.9
Employee cost	56.3	74.1	88.7	135.7
Other costs	497.4	797.6	754.4	737.6
Operating profit +	313.0	133.2	25.2	368.2
Operating margin %	25.8	8.9	2.0	24.1
Other income	88.8	85.4	34.8	94.4
Interest	-	3.3	0.6	2.4
Depreciation	6.3	23.5	18.9	8.0
Exceptional items	-	-5.8	-	-
Profit before tax	395.5	186.0	40.6	452.3
Tax	139.2	110.3	82.4	126.4
Profit - disc. ops	-	-	-3.4	-6.0
Net profit	256.3	75.7	-45.2	319.9
Net margin %	19.7	4.8	-3.6	19.8

Precentage of total income	Mar 2016	Mar 2017	Mar 2018	Mar 2019
Sales	93.18	94.59	97.25	94.18
Expenses +	69.61	87.85	96.79	72.11
Cost of goods	26.58	30.91	28.62	17.63
Employee cost	4.32	4.7	7.01	8.37
Other costs	38.22	50.54	59.63	45.48
Operating profit	24.05	8.44	2.0	22.7
Other income	6.82	5.41	2.75	5.82
Interest	0.0	0.21	0.05	0.15
Depreciation	0.48	1.49	1.49	0.49
Exceptional items	0.0	-0.36	0.0	0.0
Profit before tax	30.39	11.79	3.21	27.89
Tax	10.7	6.99	6.52	7.79
Profit - disc. ops	0.0	0.0	-0.27	-0.37
Net profit	19.69	4.8	-3.57	19.73

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2016	Mar 2017	Mar 2018	Mar 2019
Solvency +
Total Debt/Equity	0.0	0.0	0.0	0.0
Net Debt/Equity	0.0	0.0	0.0	0.0
Total Debt/Assets	0.0	0.0	0.0	0.0
Total Assets/Equity	1.2	1.6	1.8	1.4
Liquidity +
Current Ratio	6.0	2.4	1.9	2.8
Quick Ratio	4.9	1.3	1.8	2.7
Interest Coverage	-	40.2	42.8	156.2
Performance
Gross Margin	71.5	67.3	70.6	81.3
Operating Margin	25.8	8.9	2.0	24.1
Net Margin	19.7	4.8	-3.6	19.8
Return +
Return on Equity	16.4	10.3	-6.5	31.6
Pre-tax ROCE	20.5	16.6	1.2	43.5
Return on Assets	13.5	6.3	-3.7	21.8
Pre-tax ROIC	19.6	14.9	0.9	35.6
Efficiency +
Days Payable	221.0	186.0	334.0	375.0
Days Inventory	303.0	312.0	83.0	78.0
Days Receivable	32.0	39.0	32.0	24.0
Fixed Asset Turnover	9.3	13.2	13.8	41.6
Total Asset Turnover	0.6	1.2	1.0	1.0
Working Capital
Cash Conversion Cycle	114.0	165.0	-219.0	-273.0
Working Capital Days	411.0	134.0	136.0	189.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

As per information available, the company has no registered charges.

People

Designation	Name	DIN/PAN	Tenure
Director	Ramesh Chander Gupta	02314913	16 years
Whole-time Director	Anurita Chopra	07607315	9 years
Whole-time Director	Kanika Shah Wadhwa	08386613	6 years
Whole-time Director	Nitin Mathur	09046346	4 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
Chiron Behring Vaccines Private Limited	India	-	-

Registered Details

CIN

U99999PB1995PTC028476

PAN

AABCS3237R

Incorporation

1995, 29.5 years

Company Email

kanika.x.shahwadhwa@haleon.com

Paid up Capital

₹ 5.5 Cr

Authorised Capital

₹ 10.0 Cr

AGM

Sep 2023

Type

Private

Non-government Company

FAQ - GLAXOSMITHKLINE ASIA PRIVATE LIMITED

What is the incorporation date of GLAXOSMITHKLINE ASIA PRIVATE LIMITED?

The incorporation date of GLAXOSMITHKLINE ASIA PRIVATE LIMITED is 18 October, 1995

What is the authorized share capital of GLAXOSMITHKLINE ASIA PRIVATE LIMITED?

The authorized share capital of GLAXOSMITHKLINE ASIA PRIVATE LIMITED is INR ₹ 10.0 Cr.

What is the paid-up capital of GLAXOSMITHKLINE ASIA PRIVATE LIMITED?

The paid-up capital of GLAXOSMITHKLINE ASIA PRIVATE LIMITED is INR ₹ 5.5 Cr.

What is the registered address of GLAXOSMITHKLINE ASIA PRIVATE LIMITED?

The registered address of GLAXOSMITHKLINE ASIA PRIVATE LIMITED is Patiala Road Nabha NA Patiala Patiala Punjab - 147201

What is the CIN number of GLAXOSMITHKLINE ASIA PRIVATE LIMITED?

The CIN number of GLAXOSMITHKLINE ASIA PRIVATE LIMITED is U99999PB1995PTC028476.

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

GLAXOSMITHKLINE ASIA PRIVATE LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

People

Company Network